课题基金 / 基金详情

Role of Pertussis Toxin in Bordetella pertussis infection

Role of Pertussis Toxin in Bordetella pertussis infection
百日咳毒素在百日咳博德特氏菌感染中的作用
批准号:
7033537
负责人:
NICHOLAS H CARBONETTI
金额:
$37.13万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2010-11-30

项目摘要

项目成果

NICHOLAS H CARBONETTI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bordetella pertussis is a gram-negative bacterial pathogen that infects the human respiratory tract, leading to a severe paroxysmal coughing disease known as whooping cough that can be fatal in infants. The mechanisms that this pathogen employs to establish an infection and cause disease are still relatively obscure. In addition, although there has been extensive characterization in vitro of the structure and function of several putative B. pertussis virulence factors, the roles that these factors play in the host-pathogen interaction to promote infection and disease are poorly understood. The overall goal of this project is to determine the role that one of these factors, pertussis toxin (PT), plays in respiratory tract infection by B. pertussis. PT is an exotoxin produced exclusively by this pathogen and can intoxicate a wide range of mammalian cells in culture, but its role in B. pertussis infection is largely unknown. By comparing a wild type strain (WT) to a mutant strain (deltaPT) with a deletion of the genes encoding PT in a mouse intranasal infection model, we have preliminary data that PT plays an important and early role in colonization of the respiratory tract by B. pertussis. At least three different immune responses (early neutrophil recruitment to the lungs, early cytokine and chemokine production in the respiratory tract, and serum antibody responses) to infection with WT appear to be suppressed relative to those after infection with deltaPT. Therefore, we hypothesize that an important role of PT is to suppress the antibacterial immune responses to B. pertussis, allowing establishment of the infection with subsequent disease pathogenesis. To test this hypothesis we propose four specific aims: (1) to determine the mechanism of inhibition of neutrophil recruitment to the lungs; (2) to determine the relevant targets of PT activity using chemically- and genetically-altered mice; (3) to determine whether PT suppresses lung antibody and T cell responses after B. pertussis infection; and (4) to determine whether immunosuppression by PT after B. pertussis infection enhances susceptibility to secondary infections. Elucidation of the specific roles of PT during B. pertussis infection will increase our understanding of the pathogenic mechanisms of this organism, and may lead to novel therapeutic approaches to combat pertussis infection and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systems-Level Research in Microbial Pathogenesis
  • 批准号:
    10671611
  • 项目类别:
  • 资助金额:
    $37.83万
  • 财政年份:
    2022
  • 负责人:
    NICHOLAS H CARBONETTI
  • 依托单位:
Age-dependent role of interferon lambda in protection against pertussis lethality in infants
  • 批准号:
    10591086
  • 项目类别:
  • 资助金额:
    $23.18万
  • 财政年份:
    2022
  • 负责人:
    NICHOLAS H CARBONETTI
  • 依托单位:
IDO promotes severe manifestations of B. pertussis infection in infants
  • 批准号:
    10286308
  • 项目类别:
  • 资助金额:
    $23.18万
  • 财政年份:
    2021
  • 负责人:
    NICHOLAS H CARBONETTI
  • 依托单位:
NK cell and interferon gamma deficiency in infant susceptibility to pertussis
  • 批准号:
    10369616
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2021
  • 负责人:
    NICHOLAS H CARBONETTI
  • 依托单位:
国内基金
海外基金
基于健康行为改变整合理论的艾滋病感染者自我管理生态圈网络系统构建与初步应用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    朱志红
  • 依托单位:
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    彭奕冰
  • 依托单位:
牙周炎对腹主动脉瘤的作用和机制研究
  • 批准号:
    82370953
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    朱亚琴
  • 依托单位:
基于质谱贴片的病原菌标志物检测及伤口感染诊断应用
  • 批准号:
    82372148
  • 项目类别:
    面上项目
  • 资助金额:
    60.00万元
  • 批准年份:
    2023
  • 负责人:
    黄琳
  • 依托单位: